![Bruno Lucidi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruno Lucidi
Directeur/Membre du Conseil chez
ATEA PHARMACEUTICALS, INC.
Fortune : 741 644 $ au 30/09/2026
Profil
Bruno Lucidi is currently an Independent Director at Atea Pharmaceuticals, Inc. since 2014.
Former roles include Chief Executive Officer at Karolinska Development AB (Private Equity) from 2014 to 2015, Chief Executive Officer at Aprea Therapeutics AB, Chief Executive Officer at Akinion Pharmaceuticals AB, Chief Executive Officer at KDev Oncology AB, Chief Executive Officer & Director at MiNK Therapeutics, Inc. from 2017 to 2019, Chief Executive Officer at KDventures AB from 2014 to 2015, Senior Director-Virology Europe at Bristol Myers Squibb Co. from 1994 to 1998, Vice President-Oncology & Virology at Johnson & Johnson from 2002 to 2005, and Vice President-Pediatric Vaccines at Gsk Biologicals from 2009 to 2012.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/06/2026 | 142 350 ( 0,18% ) | 741 644 $ | 30/09/2026 |
Postes actifs de Bruno Lucidi
| Sociétés | Poste | Début |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/09/2014 |
Anciens postes connus de Bruno Lucidi
| Sociétés | Poste | Fin |
|---|---|---|
| MINK THERAPEUTICS, INC. | Directeur Général | 01/09/2019 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Directeur Général | 31/01/2015 |
| KDVENTURES AB | Directeur Général | 01/01/2015 |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products | Corporate Officer/Principal | 01/01/2012 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2005 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
Gsk Biologicals
Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products | Commercial Services |
MiNK Therapeutics, Inc.
 MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
